118 related articles for article (PubMed ID: 32378556)
1. Morphine Stimulates Migration and Growth and Alleviates the Effects of Chemo Drugs via AMPK-Dependent Induction of Epithelial-Mesenchymal Transition in Esophageal Carcinoma Cells.
Zhang J; Yao N; Tian S
Biol Pharm Bull; 2020; 43(5):774-781. PubMed ID: 32378556
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
Guo H; Xiang Z; Zhang Y; Sun D
Clin Transl Oncol; 2019 Apr; 21(4):404-411. PubMed ID: 30182212
[TBL] [Abstract][Full Text] [Related]
3. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
4. Morphine stimulates cervical cancer cells and alleviates cytotoxicity of chemotherapeutic drugs via opioid receptor-dependent and -independent mechanisms.
Yu Z; Jin S; Tian S; Wang Z
Pharmacol Res Perspect; 2022 Oct; 10(5):e01016. PubMed ID: 36200813
[TBL] [Abstract][Full Text] [Related]
5. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
[TBL] [Abstract][Full Text] [Related]
6. Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation.
Ma Z; Fan C; Yang Y; Di S; Hu W; Li T; Zhu Y; Han J; Xin Z; Wu G; Zhao J; Li X; Yan X
Sci Rep; 2016 Oct; 6():35196. PubMed ID: 27731378
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
[TBL] [Abstract][Full Text] [Related]
8. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
9. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK.
Zhang Y; Peng X; Zheng Q
Biochem Biophys Res Commun; 2018 Jul; 501(4):1074-1079. PubMed ID: 29777701
[TBL] [Abstract][Full Text] [Related]
10. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
[TBL] [Abstract][Full Text] [Related]
11. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
[TBL] [Abstract][Full Text] [Related]
12. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
13. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
Jeon MJ; Kim WG; Lim S; Choi HJ; Sim S; Kim TY; Shong YK; Kim WB
Mol Cell Endocrinol; 2016 Jan; 419():113-23. PubMed ID: 26463583
[TBL] [Abstract][Full Text] [Related]
14. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
[TBL] [Abstract][Full Text] [Related]
15. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
16. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma.
Kanamoto A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Nov; 49(5):1859-1869. PubMed ID: 27826618
[TBL] [Abstract][Full Text] [Related]
19. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.
Gao Y; Chen DL; Zhou M; Zheng ZS; He MF; Huang S; Liao XZ; Zhang JX
Cell Death Dis; 2020 Oct; 11(10):866. PubMed ID: 33067427
[TBL] [Abstract][Full Text] [Related]
20. Luteolin combined with low-dose paclitaxel synergistically inhibits epithelial-mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo.
Qin T; Zhao J; Liu X; Li L; Zhang X; Shi X; Ke Y; Liu W; Huo J; Dong Y; Shen Y; Li Y; He M; Han S; Li L; Pan C; Wang C
Phytother Res; 2021 Nov; 35(11):6228-6240. PubMed ID: 34494324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
